Author of: MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ in Nature Communications: https://nitter.gq/t.co/SSLroOGLk8
Cincinnati Children's Hospital
Joined January 2019
- Tweets359
- Following587
- Followers725
- Likes2K
We made it to the cover page!! See our latest findings in TIE2 mutant endothelial cells in Venous Malformations in @atvbahajournals ahajournals.org/doi/full/10.…
I refreshed 100 times and this score is still there.. I am so happy and proud of my team that helped me achieve this result!
😁 so exciting to see some of my work highlighted by @MiikkaVikkula , the Benditt Award recipient at the NAVBO vascular biology meeting @vascularbiology
Submit your favorite patient-derived vascular research method @JoVEJournal
app.jove.com/methods-collect…
Yesterday we had a fun lab outing at the Cincinnati zoo to celebrate our publication in @NatureComms the 🌷 are so beautiful! nature.com/articles/s41467-0…
Happy to share our latest publication in @NatureComms We developed a murine model for GNAQ mutated vascular tumors and coagulopathy and showed that MEK inhibition prevents tumor formation improving survival. great work by @SchrenkSandra and Collaborators
Congratulations Stefania for a so well deserved Folkman Award! @NicoliLab @ivbm2022 @vascularbiology
In Oakland , ready and very excited for IVBM! Salute! Cheers! @ivbm2022 @vascularbiology with @SchrenkSandra
